<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01033539</url>
  </required_header>
  <id_info>
    <org_study_id>CSP U-08-008 BSS</org_study_id>
    <nct_id>NCT01033539</nct_id>
  </id_info>
  <brief_title>To Demonstrate That Lactobacillus Reuteri ATCC PTA 4659 Survives Passage Through the Gastrointestinal Tract of Humans</brief_title>
  <official_title>To Demonstrate That Lactobacillus Reuteri ATCC PTA 4659 Survives Passage Through the Gastrointestinal Tract of Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Good Food Practice, Sweden</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Good Food Practice, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of a sachet containing Lactobacillus
      Reuteri ATCC PTA 4659 on the recovery of live Lactobacillus reuteri in fecal samples after 7,
      14 and 28 days supplementation as well as 14 days wash out compared to the same sachet
      without the probiotic bacteria as placebo control.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is the first to investigate the relative colonisation of the human GI tract by L
      Reuteri ATCC PTA 4659. Simple demonstration that they survive passage is the first step in
      development of potential new probiotics, which is necessary before these strains can be
      considered for continued testing in probiotic food matrices. The aim of this study will
      evaluate the safety and tolerability of Lactobacillus Reuteri in healthy adult subjects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change form baseline to day 28 on treatment in level of live Lactobacillus Reuteri ATC PTA 4659 in faecal material.</measure>
    <time_frame>Nov 2009-April2010</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Recovery of Lactobacillus Reuteri ATCC PTA 4659</condition>
  <condition>The Safety of Lactobacillus Reuteri ATCC PTA 4659</condition>
  <arm_group>
    <arm_group_label>Placebo control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Placebo control without probiotics ATCC PTA 4659</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ATCC PTA 4659 Low dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ATCC PTA 4659 high dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Probiotic strain ATCC PTA 4659</intervention_name>
    <description>Placebo control containing no probiotic strain of ATCC PTA 4659 High dose of ATCC PTA 4659 1*10 10 CFU/bag Low dose of ATCC PTA 4659 1*10 8 CFU/bag</description>
    <arm_group_label>Placebo control</arm_group_label>
    <arm_group_label>ATCC PTA 4659 Low dose</arm_group_label>
    <arm_group_label>ATCC PTA 4659 high dose</arm_group_label>
    <other_name>ATCC PTA 4659</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females

          -  Age 18-65 years

          -  BMI 19-33

          -  Hb 120 g/women 130 g/l for men

          -  Healthy assessed by screening tests and physical examination

          -  Signed informed consent and bio bank consent

        Exclusion Criteria:

          -  Participation in a clinical study within 90 days prior screening use of antibiotics 2
             weeks before baseline

          -  Pregnant or lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birgitta E Sundberg, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Good Food Practice, Uppsala, Sweden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Good Food Practice</name>
      <address>
        <city>Uppsala</city>
        <zip>751 83</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2009</study_first_submitted>
  <study_first_submitted_qc>December 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2009</study_first_posted>
  <last_update_submitted>March 28, 2012</last_update_submitted>
  <last_update_submitted_qc>March 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Survive</keyword>
  <keyword>safety</keyword>
  <keyword>lactobacillus Reuteri</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

